Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.American Journal of Hematology|February 14, 2020
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphomaJohn Timmerman, Charles Herbaux, Vincent Ribrag, et al.American Journal of Hematology|December 23, 2024
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell LymphomaSwetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, et al.Transplantation and Cellular Therapy|January 12, 2026
Impact of Complete Response on Long-Term Survival in Patients With Relapsed or Refractory Large B-cell Lymphoma: A CIBMTR Prospective Study and SLR/Meta-AnalysisArmin Ghobadi, Theodora Anagnostou, Jacques Azzi, et al.Blood Advances|March 4, 2020
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphomaReid W Merryman, Natasha Edwin, Robert Redd, et al.Nature Communications|August 12, 2025
A clonally expanded nodal T-cell population diagnosed as T-cell lymphoma after CAR-T therapyKatie Maurer, Jackson A Weir, Adi Nagler, et al.Scientific Reports|November 22, 2022
EEG-based grading of immune effector cell-associated neurotoxicity syndromeDaniel K Jones, Christine A Eckhardt, Haoqi Sun, et al.Blood|September 6, 2024
Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphomaKatie Maurer, Isabella N Grabski, Roch Houot, et al.Nature Medicine|September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaNicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.Transplantation and Cellular Therapy|July 7, 2024
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow TransplantationMadiha Iqbal, Ambuj Kumar, Peter Dreger, et al.Pageof 4